Narrative Review of Traditional Chinese Medicine in the Treatment of Postmenopausal Osteoporosis


Citar

Texto integral

Resumo

:An increasing percentage of people in China are suffering from osteoporosis, particularly postmenopausal osteoporosis (PMOP), as the country rapidly evolves into an aging culture. Patients with osteoporosis are inclined to endure fractures, as well as deformities and impairments, which drastically decrease people’s quality of life. The benefits of traditional Chinese medicine (TCM) treatment have continued to become increasingly apparent as reports of adverse responses to Western medications increased. The main advantage of traditional Chinese medicine treatment is that pharmacological interactions may be employed to lessen adverse effects while increasing therapeutic efficacy. In addition, there are various exercise therapies created by medical doctors in the past generations, such as: Wuqinxi, Taijiquan, Baduanjin, Yijinjing, etc. Chinese medicine and exercise treatment for postmenopausal osteoporosis have garnered a lot of attention recently both domestically and internationally, and investigations demonstrate that these therapies have considerable therapeutic effects. The pathophysiology of postmenopausal osteoporosis, advancements of herbal therapy options, and exercise treatment options are all thoroughly addressed in this article.

Sobre autores

Li Qi

First School of Clinical Medicine, Shandong Traditional Chinese Medicine University

Email: info@benthamscience.net

Wang Wei Guo

Department of Orthopaedics, Affiliated Hospital of Shandong University of Chinese Medicine

Autor responsável pela correspondência
Email: info@benthamscience.net

Huang Xu Dong

First School of Clinical Medicine, Shandong Traditional Chinese Medicine University

Email: info@benthamscience.net

Zhao Xiu Mei

Second Department of Clinical Psychology, Shandong Mental Health Center

Email: info@benthamscience.net

Xu Xiao Dong

First School of Clinical Medicine, Shandong Traditional Chinese Medicine University

Email: info@benthamscience.net

Zhang Cheng Ming

First School of Clinical Medicine, Shandong Traditional Chinese Medicine University

Email: info@benthamscience.net

Bibliografia

  1. Consensus development conference. Diagnosis, prophylaxis, and treatment of osteoporosis. Am. J. Med., 1993, 94(6), 646-650. doi: 10.1016/0002-9343(93)90218-E PMID: 8506892
  2. Huizi, O.; Jun, H. Progress in the analysis of chemical composition of Epimedium and its pharmacokinetic study. J. Tianj. Univ. Tradit. Chin. Med., 2019, 38(03), 219-227.
  3. Ma, D.; Lan, Z.; Lin, L. Anti-inflammatory effect of Epimedium extract and its mechanism. Adv. Biochem. and Biophys., 2020, 47(08), 685-699. in English
  4. Zhuang, H. Acute phase adverse drug reaction study of zoledronic acid injection in the treatment of postmenopausal primary osteoporosis. Chin. J. Clin. Pharmacol., 2019, 35(11), 1119-1121.
  5. Gao, Sidong Effects of Epimedium and estrogen on osteogenic differentiation of rat bone marrow mesenchymal stem cells. Zhongguo Guzhi Shusong Zazhi, 2022, 28(02), 174-177.
  6. Peng, D.; Deng, M.; Zhang, L. The effect of Eucommia globulus leaves on bone metabolism in deactivated osteoporotic rats. Zhongguo Guzhi Shusong Zazhi, 2012, 18(12), 1127-1130.
  7. Liu, Y.; Bo, Z.; Wei, L. Effects of Eucommia globulus leaf alcohol extract on biochemical indexes of bone metabolism, bone mineral density, IL-6 and TNF-α in de-ovalized osteoporotic rats. J. Chin. Med., 2018, 33(03), 445-448.
  8. Yao, L.; Chen, L.; Guan, Z. Effects of Eucommia globulus extract on bone metabolism, bone mineral density and bone microstructure in de-ovalized osteoporotic rats. Chin. Herb. Med., 2016, 39(11), 2624-2628.
  9. Fan, X.; Feng, C.; Wenna, Y. Exploring the mechanism of action of Qing’e pill for postmenopausal osteoporosis based on systemic pharmacology and molecular docking. Zhongguo Guzhi Shusong Zazhi, 2021, 27(05), 735-741.
  10. Manolagas, S.C. From estrogen-centric to aging and oxidative stress: A revised perspective of the pathogenesis of osteoporosis. Endocr. Rev., 2010, 31(3), 266-300. doi: 10.1210/er.2009-0024 PMID: 20051526
  11. Hong, C.; Jia, W.; Qi, Y. Study on the antioxidant mechanism of Astragalus membranaceus in the treatment of postmenopausal osteoporosis. Int. J. Obste. and Gynecol., 2015, 42(05), 504-507.
  12. Sun, X. Effect of astragalus polysaccharides on ovariectomy-induced osteoporosis in mice. Genet. Mol. Res., 2016, 15(4)
  13. Chen, S. Zhang, Hongqin; Qiuqin, Chen Intervention effect of total flavonoids of Boneset on osteoporosis in ovarian denuded rats. Chi. Cont. Med., 2021, 28(10), 4-7.
  14. Feng, C.; Zhang, X.; Yueppin, C. Network-based pharmacology and bioinformatics study on the mechanism of action of Bone Crushed Tonic and Epimedium in the treatment of osteoporosis. Zhongguo Guzhi Shusong Zazhi, 2021, 27(05), 727-734.
  15. Peng, F.; Gan, D.; Wang, W. Molecular mechanism of Shu Di Huang’s intervention in osteoporosis based on network pharmacology. Shandong Journal of Traditional Chinese Medicine, 2020, 39(02), 177-184.
  16. Pin, Li; Lin, Shen Yang, Yanpin Clinical study of Qing'e Pill in the treatment of postmenopausal osteoporosis (kidney deficiency and blood stasis). Integrated study of Chinese and Western medicine, 2014, 6(6), 281-285.
  17. Dai, L.; Fan, Y.; Ning, G. Effects of Qing Moth Pill-containing serum on the induction of MMP3/OPN pathway protein levels in osteoblasts and bone reconstruction in vitro. J. Chin. Patent Medicine, 2016, 38(7), 1621-1625.
  18. INSTITUTE OF CHINESE MATERIA MEDICA S U O T. Treatment with Qing’E, a kidney-invigorating Chinese herbal formula, antagonizes the estrogen decline in ovariectomized mice. 11th National Conference of the Chinese Pharmacological Society, 2011.
  19. Yang, W.; Guo, W.; Cheng, L.M. Systematic evaluation and meta-analysis of the efficacy of Liu Wei Di Huang Wan in the treatment of postmenopausal osteoporosis. Zhongguo Guzhi Shusong Zazhi, 2020, 26(05), 663-670.
  20. Gong, R.; Ren, S.; Chen, M.; Wang, Y.; Zhang, G.; Shi, L.; Zhang, C.; Su, R.; Li, Y. Bioinformatics analysis reveals the altered gene expression of patients with postmenopausal osteoporosis using liuweidihuang pills treatment. BioMed Res. Int., 2019, 2019, 1907906. PMID: 30809532
  21. Rui, G.; Shan, R.; Chen, M.L. Gene expression profiling in postmenopausal osteoporosis patients with the intervention of Liu Wei Di Huang Wan. J. Mod. Trad. Chin. Western Med., 2020, 29(08), 828-834.
  22. Yu, X-B.; Ma, J-Q.; Dong, W. Effects of Liou Wei Di Huang Wan on osteocalcin, bone mineral density and JAK/STAT signaling pathway in the treatment of postmenopausal osteoporosis with kidney yin deficiency evidence. Chin. Herb. Med., 2020, 43(03), 734-737.
  23. Yang, Yiran Screening of whole blood differential protein in postmenopausal patients with osteoporosis by LC-MS. Zhongguo Guzhi Shusong Zazhi, 2019, 25(12), 1676-1679.
  24. Liang, Bocheng; Min, Li Wang, Junhua Exploring the target and mechanism of action of strong bone drink against primary type I osteoporosis based on systems biology Chinese general medicine, 2019, 17(6), 909-914.
  25. Liang, B.C.; Shi, X.L.; Li, C.W.; Shi, Z.Y.; He, W.T.; Yao, J.L.; Kong, L.C.; Li, X.Y. Identification of human serum protein targets of Qianggu Decoction () in primary type I osteoporosis based on tandem mass tag labeling and liquid chromatography-tandem mass spectrometry technology. Chin. J. Integr. Med., 2017, 23(10), 747-754. doi: 10.1007/s11655-016-2600-4 PMID: 27389089
  26. Tang, B.; Kang, L.; Wu, L. Preliminary study on the influence of osteoclast exosomes on osteoblast differentiation by strong bone drink. Zhongguo Guzhi Shusong Zazhi, 2020, 26(11), 1598-1603.
  27. Liu, G.; Wang, J.; Li, Z. Clinical study on the treatment of postmenopausal osteoporosis with Strong Bone Drink. Chinese Pharmacovigilance, 2014, 11(11), 652-656.
  28. Liu, F-X.; Fan, Q-L.; Feng, T. Study on the activation of ALP and OPN proteins by Zuo Gui Wan-containing serum to promote the proliferation and differentiation of BMSCs. Zhongguo Guzhi Shusong Zazhi, 2022, 28(05), 653-657.
  29. Sha, L. Tan Cong’e. Advances in the molecular signaling pathways of Dougui Pill to intervene in related diseases. Global Chinese Medicine, 2022, 15(05), 902-906.
  30. Min, L.; Shi, X.; Chao, X. Pharmacological mechanisms of action of Chinese herbal compounds and target networks in the anti-osteoporosis of Dougui Wan. China Bone Injury, 2020, 33(10), 933-937.
  31. Wibo, X.; Zhang, Z.; Hua, L. Guidelines for the diagnosis and treatment of primary osteoporosis (2017). Zhongguo Guzhi Shusong Zazhi, 2019, 25(03), 281-309.
  32. Huang, H.W.Q.; Li, X. Expert consensus on muscle, bone and osteoporosis. Zhongguo Guzhi Shusong Zazhi, 2016, 22(10), 1221-1229.
  33. Li, J.W.; Pan, D.; Li, X. Clinical study of modified five birds play with strong bone drinking granules in the treatment of primary osteoporosis. Journal of Shaanxi College of Traditional Chinese Medicine, 2014, 37(06), 64-66.
  34. Li, J.; Pan, D.; He, K. Clinical application experience of modified five birds play for the prevention and treatment of primary type I osteoporosis. Zhongguo Guzhi Shusong Zazhi, 2014, 20(08), 920-923.
  35. Lin, Z.; Wei, Y. advances in clinical research on five animal play at home and abroad. Massage and Rehabilitation Medicine, 2019, 10(23), 24-27.
  36. Ruan, C.; Chen, F.; Liu, Z. Effects of long-term aerobic exercise on estrogen and bone composition in women with osteoporosis. Zhongguo Guzhi Shusong Zazhi, 2016, 22(02), 159-162.
  37. Chen, W.; Mao, Y.; Zhang, J. Clinical efficacy of Yi Wen Wen Jing Formula combined with the new five animal play on postmenopausal patients with reduced bone mass. Zhongguo Guzhi Shusong Zazhi, 2018, 24(07), 954-958.
  38. Jing, Z. Changes in bone mineral density in perimenopausal women after receiving taijiquan exercise. Chinese Tissue Engineering Research, 2020, 24(02), 176-180.
  39. Zeng, L.; Yang, W.; Liang, G. Systematic evaluation of the efficacy and safety of traditional Tai Chi gongfu intervention on improving bone density loss. Chinese Tissue Engineering Research, 2019, 23(27), 4420-4428.
  40. Long, L.; Tao, H.; Zhu, L. Meta-analysis of the effect of tai chi exercise on the prevention and treatment of osteoporosis. Zhongguo Guzhi Shusong Zazhi, 2019, 25(09), 1280-1289.
  41. Li, F.; Harmer, P.; Fitzgerald, K.; Eckstrom, E.; Akers, L.; Chou, L.S.; Pidgeon, D.; Voit, J.; Winters-Stone, K. Effectiveness of a therapeutic Tai Ji Quan intervention vs a multimodal exercise intervention to prevent falls among older adults at high risk of falling. JAMA Intern. Med., 2018, 178(10), 1301-1310. doi: 10.1001/jamainternmed.2018.3915 PMID: 30208396
  42. Harmer, P.A. So much research, so little application: Barriers to dissemination and practical implementation of Tai Ji Quan. J. Sport Health Sci., 2014, 3(1), 16-20. doi: 10.1016/j.jshs.2013.10.005 PMID: 25089214
  43. Zhang, C.; Jun, Z.; Qiang, D. Prevention of postmenopausal osteoporosis by combining traditional Chinese and Western medicine based on the theory of "treating the untreated disease and preventing the untreated disease first". Western Traditional Chinese Medicine, 2017, 30(01), 69-72.
  44. Su, J.; Qiang, D. Clinical study on the treatment of postmenopausal osteoporosis with Baduanjin combined with anti-osteoporosis drugs. J. Tradit. Chin. Med., 2018, 46(03), 84-88.
  45. Bao, X.; Qiu, Q.X.; Shao, Y.J.; Quiben, M.; Liu, H. Effect of sitting ba-duan-jin exercises on balance and quality of life among older adults: a preliminary study. Rehabil. Nurs., 2020, 45(5), 271-278.
  46. Xing, J.; Xu, G.; Meng, Z. Effect of virtual reality-based rehabilitation training on balance function of patients recovering from traumatic brain injury. Chin. J. Phy. Med. Rehab., 2016, 38(06), 406-408.
  47. Sun, Z.; Gu, X.; Gang, O. Effect of virtual reality-based Badaanjin on fall risk and quality of life of elderly patients with osteoporosis in nursing homes. China Medicine Herald, 2020, 17(01), 90-93.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bentham Science Publishers, 2024